Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
167,540,263
-
Share change
-
+26,782,015
-
Total reported value
-
$2,291,592,391
-
Put/Call ratio
-
196%
-
Price per share
-
$13.69
-
Number of holders
-
200
-
Value change
-
+$415,822,271
-
Number of buys
-
110
-
Number of sells
-
88
Institutional Holders of ARIAD PHARMACEUTICALS INC - COM (ARIA) as of Q3 2016
As of 30 Sep 2016,
ARIAD PHARMACEUTICALS INC - COM (ARIA) was held by
200 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
167,540,263 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, VANGUARD GROUP INC, Sarissa Capital Management LP, Consonance Capital Management LP, BlackRock Fund Advisors, STATE STREET CORP, PUTNAM INVESTMENTS LLC, PRICE T ROWE ASSOCIATES INC /MD/, and WESTFIELD CAPITAL MANAGEMENT CO LP.
This page lists
200
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.